WINNIPEG — The Manitoba government has added 79 drugs to soon be covered under the Manitoba Pharmacare Program.
Some of the new additions include:
• Actikerall for the treatment of a skin disorder called hyperkeratotic actinic keratosis;
• Dysport Therapeutic for the treatment of lower limb spasticity;
• Kyleena for conception control;
• Lancora for the treatment of heart failure;
• Revestive for the treatment of short bowel syndrome (SBS); and
• Spinraza for Type 1 spinal muscular atrophy (SMA).
“Medications are important treatments for many different illnesses and diseases,” said Health, Seniors and Active Living Minister Cameron Friesen. “Manitoba’s universal prescription drug benefit program is one of the most comprehensive in the country and these new additions will help families across the province access drug coverage through the program.”
The province says of the 79 new additions, 73 are generic medications at different strengths
Coverage for the new drugs will be effective on January 24, 2019.
